FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia
about
Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibodyCXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso-occlusion during hemolytic transfusion reactionsMechanisms of Autoantibody-Induced Pathology.Exacerbation of autoantibody-mediated hemolytic anemia by viral infection.The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis.Clearance of pathological antibodies using biomimetic nanoparticles.FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo.Critical role of NKT cells in posttransplant alloantibody production.Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.Cooperative and alternate functions for STIM1 and STIM2 in macrophage activation and in the context of inflammationAntibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors.Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosisHigh pathogenic potential of low-affinity autoantibodies in experimental autoimmune hemolytic anemia.The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapyFcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.FcgammaRIII is protective against Pseudomonas aeruginosa pneumoniaFcγ Receptor Heterogeneity in Leukocyte Functional Responses.C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.Dynamics of the interaction of human IgG subtype immune complexes with cells expressing R and H allelic forms of a low-affinity Fc gamma receptor CD32A.Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice.Increased survival and reduced renal injury in MRL/lpr mice treated with a human Fcγ receptor II (CD32) peptide.The role of Fc-receptors in murine mercury-induced systemic autoimmunity.
P2860
Q24674255-BD3C187C-8F33-406B-BA01-91D07643FF1BQ30499303-05E1294A-0D4B-4148-8232-AC8591DFCCADQ33740580-31BF1695-FD68-47E0-AC89-BE2DC185EBB9Q33806833-F8B342D6-A27D-4377-B967-93AF005D14DEQ33931736-2D087CC6-3408-46FA-9379-F973BD430CDEQ34218004-8FD9C0D0-4D0E-41DA-8234-92F73CC0CC56Q34320482-5830ED41-552A-4689-9700-D3D0E43FA0B5Q34392504-422D4F0F-98EE-4B7E-9840-1E93F3ABFA26Q34542687-137510DD-ADE6-4D6E-8537-2ECA3E353D86Q36082310-DA6A613E-5183-4364-A937-67CE84F6CF4DQ36228329-37103C53-3AC2-4BE5-B02C-EE1F07D367C0Q36228422-4EABB2E0-BB20-4BB3-B228-48822FCFB7B5Q36368392-020A6FDD-03D7-42CA-9153-F3414CCC0839Q36369098-A436B606-DCBC-48F0-A2F6-9BE03D1A0E55Q36375688-673A5503-BDD2-4A26-B60C-B90AD07D0B25Q36402637-50357F9B-02E9-4D5F-861B-29FF7FE2F42DQ36421562-1E2BE522-F8B9-49A5-BF94-2B0EF4E5A201Q36508708-0F4D4C0E-EF7D-49D9-90A8-5AEEE7466C9DQ39217862-A39575AF-C1BA-43E4-8742-66A83C1765F6Q39740184-69C51DE9-CC2B-45D9-B761-F22E8451F1D1Q39763737-C1D7C324-C393-4539-8E78-4F4FFACDF4F2Q41908124-77634CF4-D177-4DB6-9AD8-BF2B8C235AC1Q51368948-9BA79C4D-F376-4E9D-A782-4AE3D5C2BD31Q53626063-CB483470-D2BD-47DF-91CB-F242E9985C00
P2860
FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia
description
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1998
@ast
im Dezember 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1998/12/01)
@sk
vědecký článek publikovaný v roce 1998
@cs
wetenschappelijk artikel (gepubliceerd op 1998/12/01)
@nl
наукова стаття, опублікована в грудні 1998
@uk
مقالة علمية (نشرت في ديسمبر 1998)
@ar
name
FcgammaRIII (CD16)-deficient m ...... al autoimmune hemolytic anemia
@ast
FcgammaRIII (CD16)-deficient m ...... al autoimmune hemolytic anemia
@en
FcgammaRIII (CD16)-deficient m ...... al autoimmune hemolytic anemia
@nl
type
label
FcgammaRIII (CD16)-deficient m ...... al autoimmune hemolytic anemia
@ast
FcgammaRIII (CD16)-deficient m ...... al autoimmune hemolytic anemia
@en
FcgammaRIII (CD16)-deficient m ...... al autoimmune hemolytic anemia
@nl
prefLabel
FcgammaRIII (CD16)-deficient m ...... al autoimmune hemolytic anemia
@ast
FcgammaRIII (CD16)-deficient m ...... al autoimmune hemolytic anemia
@en
FcgammaRIII (CD16)-deficient m ...... al autoimmune hemolytic anemia
@nl
P2093
P921
P1433
P1476
FcgammaRIII (CD16)-deficient m ...... al autoimmune hemolytic anemia
@en
P2093
C. Schiller
J. E. Gessner
J. S. Verbeek
J. Westermann
R. E. Schmidt
W. L. Hazenbos
P304
P407
P577
1998-12-01T00:00:00Z